Chahra Louafi is Investment Director and head of the fund for biotherapies and rare diseases at Bpifrance (previously CDC Entreprises). Prior to joining CDC Entreprises, she was in charge of project development and company creation in a private incubator specialized in biotechnologies. At CDC Entreprises, Chahra worked with the New Developments team and was responsible for technology transfer operations and investments in funds of funds focused on the financing of start-ups.
She is Vice-president of the supervisory board of Inserm Transfert Initiative and member of the supervisory board of Cap Décisif Management. She sits on several boards including DBV Technologies, Sensorion, Eyevensys, Pixium Vision and Lysogene.